Previous Next

REFERENCES

301. Hussain A: Anaesthesia for heart transplantation. Br J Hosp Med 54:466–468, 1995.

302. Lindelow B, Andersson B, Waagstein F, et al: High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. Eur Heart J 20:148–156, 1999.

303. Espinoza C, Manito N, Roca J, et al: Reversibility of pulmonary hypertension in patients evaluated for orthotopic heart transplantation: Importance in the postoperative morbidity and mortality. Transplant Proc 31:2503–2504, 1999.

304. Tenderich G, Koerner MM, Stuettgen B, et al: Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient >15 mm Hg or >5 Wood) predict early and long-term results after orthotopic heart transplantation? Transplant Proc 30:1130–1131, 1998.

305. Chen JM, Levin HR, Michler RE, et al: Reevaluating the significance of pulmonary hypertension before cardiac transplantation: Determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg 114:627–634, 1997.

306. Omoto T, Hansky B, Minami K, et al: Successful bridging by biventricular pacing for heart transplantation. Ann Thorac Surg 74:1684–1685, 2002.

307. Mohacsi P, Rieben R, Sigurdsson G, et al: Successful management of a B-type cardiac allograft into an O-type man with 3{1/2}-year clinical follow-up. Transplantation 72:1328–1330, 2001.

308. Betkowski AS, Graff R, Chen JJ, et al: Panel-reactive antibody screening practices prior to heart transplantation. J Heart Lung Transplant 21:644–650, 2002.

309. Baumgartner WA: Operative techniques used in heart transplantation. In Baumgartner R, Kaper T (eds): Heart and Lung Transplantation. Philadelphia, WB Saunders, 2002.

310. Conte JV, Baumgartner R: Operative technique of single-lung, bilateral lung, and heart-lung transplantation. In Baumgartner R, Kaper T (eds): Heart and Lung Transplantation. Philadelphia, WB Saunders, 2002.

311. Campion EW: A death at Duke. N Engl J Med 348:1083–1084, 2003.

312. Kitamura S, Nakatani T, Bando K, et al: Modification of bicaval anastomosis technique for orthotopic heart transplantation. Ann Thorac Surg 72:1405–1406, 2001.

313. el Gamel A, Yonan NA, Grant S, et al: Orthotopic cardiac transplantation: A comparison of standard and bicaval Wythenshawe techniques. J Thorac Cardiovasc Surg 109:721–729, discussion 729–730, 1995.

314. Dreyfus G, Jebara V, Mihaileanu S, et al: Total orthotopic heart transplantation: An alternative to the standard technique. Ann Thorac Surg 52:1181–1184, 1991.

315. Blanche C, Czer LS, Valenza M, et al: Alternative technique for orthotopic heart transplantation. Ann Thorac Surg 57:765–767, 1994.

316. Aranda JM Jr, Schofield RS, Pauly DF, et al: Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: A prospective, randomized trial. Am Heart J 145:324–329, 2003.

317. de Boer WJ, Waterbolk TW, Brugemann J, et al: Extracorporeal membrane oxygenation before induction of anesthesia in critically ill thoracic transplant patients. Ann Thorac Surg 72:1407–1408, 2001.

318. Felker GM, O'Connor CM: A bridge for the 21st century in heart transplantation? Am Heart J 145:198–199, 2003.

319. Dressler DK: Heart transplantation: A review. J Transpl Coord 9:25–32, quiz 33–34, 1999.

320. Hunt SA, Frazier OH: Mechanical circulatory support and cardiac transplantation. Circulation 97:2079–2090, 1998.

321. Stone ME, Soong W, Krol M, et al: The anesthetic considerations in patients with ventricular assist devices presenting for noncardiac surgery: A review of eight cases. Anesth Analg 95:42–49, 2002.

322. Berberich JJ, Fabian JA: A retrospective analysis of fentanyl and sufentanil for cardiac transplantation. J Cardiothorac Anesth 1:200–204, 1987.

323. Firestone L: Heart transplantation. Int Anesthesiol Clin 29:41–58, 1991.

324. O'Kelly SW, Hayden-Smith J: Eisenmenger's syndrome: Surgical perspectives and anaesthetic implications. Br J Hosp Med 51:150–153, 1994.

325. Kyriss T, Wurst H, Friedel G, et al: Reduced blood loss by aprotinin in thoracic surgical operations associated with high risk of bleeding. A placebo-controlled, randomized phase IV study. Eur J Cardiothorac Surg 20:38–41, 2001.

326. Royston D: High-dose aprotinin therapy: A review of the first five years' experience. J Cardiothorac Vasc Anesth 6:76–100, 1992.

2281


327. Royston D, Bidstrup BP, Taylor KM, et al: Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 2:1289–1291, 1987.

328. Harder MP, Eijsman L, Roozendaal KJ, et al: Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. Ann Thorac Surg 51:936–941, 1991.

329. Barrons RW, Jahr JS: A review of post-cardiopulmonary bypass bleeding. Aminocaproic acid, tranexamic acid, and aprotinin. Am J Ther 3:821–838, 1996.

330. Dunn CJ, Goa KL: Tranexamic acid: A review of its use in surgery and other indications. Drugs 57:1005–1032, 1999.

331. Peters DC, Noble S: Aprotinin: An update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs 57:233–260, 1999.

332. Karski JM, Dowd NP, Joiner R, et al: The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C). J Cardiothorac Vasc Anesth 12:642–646, 1998.

333. Karski JM, Teasdale SJ, Norman P, et al: Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial. J Thorac Cardiovasc Surg 110:835–842, 1995.

334. Karski JM, Teasdale SJ, Norman PH, et al: Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid. J Cardiothorac Vasc Anesth 7:431–435, 1993.

335. Dryden PJ, O'Connor JP, Jamieson WR, et al: Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery. Can J Anaesth 44:934–941, 1997.

336. Jamieson WR, Dryden PJ, O'Connor JP, et al: Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery. Circulation 96(9 Suppl):II-96–II-100, discussion II-100–II-101, 1997.

337. Shore-Lesserson L, Reich DL, Vela-Cantos F, et al: Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery. Anesth Analg 83:18–26, 1996.

338. Royston D: Aprotinin therapy in heart and heart-lung transplantation. J Heart Lung Transplant 12(Pt 1):S19–S25, 1993.

339. Jacquet L, Ziady G, Stein K, et al: Cardiac rhythm disturbances early after orthotopic heart transplantation: Prevalence and clinical importance of the observed abnormalities. J Am Coll Cardiol 16:832–837, 1990.

340. Montero JA, Anguita M, Concha M, et al: Pacing requirements after orthotopic heart transplantation: Incidence and related factors. J Heart Lung Transplant 11(Pt 1):799–802, 1992.

341. Uberfuhr P, Frey AW, Reichart B: Vagal reinnervation in the long term after orthotopic heart transplantation. J Heart Lung Transplant 19:946–950, 2000.

342. Bengel FM, Ueberfuhr P, Hesse T, et al: Clinical determinants of ventricular sympathetic reinnervation after orthotopic heart transplantation. Circulation 106:831–835, 2002.

343. Bengel FM, Ueberfuhr P, Schiepel N, et al: Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med 345:731–738, 2001.

344. Uberfuhr P, Frey AW, Ziegler S, et al: Sympathetic reinnervation of sinus node and left ventricle after heart transplantation in humans: Regional differences assessed by heart rate variability and positron emission tomography. J Heart Lung Transplant 19:317–323, 2000.

345. Stobierska-Dzierzek B, Awad H, Michler RE: The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 38:923–931, 2001.

346. Eltzschig HK, Mihaljevic T, Byrne JG, et al: Echocardiographic evidence of right ventricular remodeling after transplantation. Ann Thorac Surg 74:584–586, 2002.

347. Carrier M, Blaise G, Belisle S, et al: Nitric oxide inhalation in the treatment of primary graft failure following heart transplantation. J Heart Lung Transplant 18:664–667, 1999.

348. Ardehali A, Hughes K, Sadeghi A, et al: Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation 72:638–641, 2001.

349. Rajek A, Pernerstorfer T, Kastner J, et al: Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E1 during heart transplantation. Anesth Analg 90:523–530, 2000.

350. Williams TJ, Salamonsen RF, Snell G, et al: Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation. J Heart Lung Transplant 14:419–423, 1995.

351. Kieler-Jensen N, Lundin S, Ricksten SE: Vasodilator therapy after heart transplantation: Effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1 , and sodium nitroprusside. J Heart Lung Transplant 14:436–443, 1995.

352. Auler Junior JO, Carmona MJ, Bocchi EA, et al: Low doses of inhaled nitric oxide in heart transplant recipients. J Heart Lung Transplant 15:443–450, 1996.

353. Paniagua MJ, Crespo-Leiro MG, Rodriguez JA, et al: Usefulness of nitric oxide inhalation for management of right ventricular failure after heart transplantation in patients with pretransplant pulmonary hypertension. Transplant Proc 31:2505–2506, 1999.

354. Adatia I: Recent advances in pulmonary vascular disease. Curr Opin Pediatr 14:292–297, 2002.

355. Ghofrani HA, Wiedemann R, Rose F, et al: Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial. Lancet 360:895–900, 2002.

356. Michelakis E, Tymchak W, Lien D, et al: Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxide. Circulation 105:2398–2403, 2002.

357. Mychaskiw G, Sachdev V, Heath BJ: Sildenafil (Viagra) facilitates weaning of inhaled nitric oxide following placement of a biventricular-assist device. J Clin Anesth 13:218–220, 2001.

358. Sastry BK, Narasimhan C, Reddy NK, et al: A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension. Indian Heart J 54:410–414, 2002.

359. Bhatia SJ, Kirshenbaum JM, Shemin RJ, et al: Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation 76:819–826, 1987.

360. Suriani RJ: Transesophageal echocardiography during organ transplantation. J Cardiothorac Vasc Anesth 12:686–694, 1998.

361. Oaks TE, Rayburn BK, Brown ME, et al: Acquired cor triatriatum after orthotopic cardiac transplantation. Ann Thorac Surg 59:751–753, 1995.

362. Terasaki PI: ABO mismatching errors in heart transplants. Lancet 362:332, 2003.

363. McGregor CG: Cardiac transplantation: Surgical considerations and early postoperative management. Mayo Clin Proc 67:577–585, 1992.

364. Burgess MI, Bhattacharyya A, Ray SG: Echocardiography after cardiac transplantation. J Am Soc Echocardiogr 15:917–925, 2002.

365. Sharpe MD: Anaesthesia and the transplanted patient. Can J Anaesth 43(5 Pt 2):R89–R98, 1996.

366. Cassivi SD, Meyers BF, Battafarano RJ, et al: Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 74:1663–1669, discussion 1669–1670, 2002.

367. Vricella LA, Karamichalis JM, Ahmad S, et al: Lung and heart-lung transplantation in patients with end-stage cystic fibrosis: The Stanford experience. Ann Thorac Surg 74:13–17, discussion 17–18, 2002.

368. Trulock EP: Lung transplantation. Am J Respir Crit Care Med 155:789–818, 1997.

369. Bracken CA, Gurkowski MA, Naples JJ: Lung transplantation: Historical perspective, current concepts, and anesthetic considerations. J Cardiothorac Vasc Anesth 11:220–241, 1997.

370. Cheng DCH, Demajo W, Sandler AN: Lung transplantation. Anesthesiol Clin North Am 12:749–765, 1994.

371. Quinlan JJ, Gasior T, Firestone S, et al: Anesthesia for living-related (lobar) lung transplantation. J Cardiothorac Vasc Anesth 10:391–396, 1996.
2282


372. Waddell TK, Bennett L, Kennedy R, et al: Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant 21:731–737, 2002.

373. Schafers HJ, Wagner TO, Demertzis S, et al: Preoperative corticosteroids. A contraindication to lung transplantation? Chest 102:1522–1525, 1992.

374. Singh H, Bossard RF: Perioperative anaesthetic considerations for patients undergoing lung transplantation. Can J Anaesth 44:284–299, 1997.

375. McRae K: Con: Lung transplantation should not be routinely performed with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 14:746–750, 2000.

376. Yang SC, Conte JV: Finer techniques in lung transplantation. Transplant Proc 32:1521–1522, 2000.

377. Triantafillou AN, Pasque MK, Huddleston CB, et al: Predictors, frequency, and indications for cardiopulmonary bypass during lung transplantation in adults. Ann Thorac Surg 57:1248–1251, 1994.

378. de Hoyos A, Demajo W, Snell G, et al: Preoperative prediction for the use of cardiopulmonary bypass in lung transplantation. J Thorac Cardiovasc Surg 106:787–795, discussion 795–796, 1993.

379. Szeto WY, Kreisel D, Karakousis GC, et al: Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome. J Thorac Cardiovasc Surg 124:241–249, 2002.

380. Hirt SW, Haverich A, Wahlers T, et al: Predictive criteria for the need of extracorporeal circulation in single-lung transplantation. Ann Thorac Surg 54:676–680, 1992.

381. de Boer WJ, Hepkema BG, Loef BG, et al: Survival benefit of cardiopulmonary bypass support in bilateral lung transplantation for emphysema patients. Transplantation 73:1621–1627, 2002.

382. Kesten S, de Hoyas A, Chaparro C, et al: Aprotinin reduces blood loss in lung transplant recipients. Ann Thorac Surg 59:877–879, 1995.

383. Gu YJ, de Haan J, Brenken UP, et al: Clotting and fibrinolytic disturbance during lung transplantation: Effect of low-dose aprotinin. Groningen Lung Transplant Group. J Thorac Cardiovasc Surg 112:599–606, 1996.

384. Jaquiss RD, Huddleston CB, Spray TL: Use of aprotinin in pediatric lung transplantation. J Heart Lung Transplant 14:302–307, 1995.

385. Hohn L, Schweizer A, Morel DR, et al: Circulatory failure after anesthesia induction in a patient with severe primary pulmonary hypertension. Anesthesiology 91:1943–1945, 1999.

386. Karanikolas MS, Triantafillou AN, Pond CG, et al: Epidural catheter placement in lung transplantation. Before or after the operation? Anesth Analg 80:SCA30, 1995.

387. Brown MJ, Licina MG, Savage RM, et al: Transesophageal echocardiography should be used during anesthesia for lung transplantation [abstract]. Anesthesiology 81(3A):A547, 1994.

388. Haddy SM, Bremner RM, Moore-Jefferies EW, et al: Hyperinflation resulting in hemodynamic collapse following living donor lobar transplantation. Anesthesiology 97:1315–1317, 2002.

389. Quinlan JJ, Buffington CW: Deliberate hypoventilation in a patient with air trapping during lung transplantation. Anesthesiology 78:1177–1181, 1993.

390. Myles PS: Lessons from lung transplantation for everyday thoracic anesthesia. Anesthesiol Clin North Am 19:581–590, vii, 2001.

391. Morisaki H, Serita R, Innami Y, et al: Permissive hypercapnia during thoracic anaesthesia. Acta Anaesthesiol Scand 43:845–849, 1999.

392. McQuitty CK: Con: Inhaled nitric oxide should not be used routinely in patients undergoing lung transplantation. J Cardiothorac Vasc Anesth 15:790–792, 2001.

393. Rocca GD, Coccia C, Pugliese F, et al: Intraoperative inhaled nitric oxide during anesthesia for lung transplant. Transplant Proc 29:3362–3366, 1997.

394. Myles PS, Venema HR: Avoidance of cardiopulmonary bypass during bilateral sequential lung transplantation using inhaled nitric oxide. J Cardiothorac Vasc Anesth 9:571–574, 1995.

395. Christie JD, Bavaria JE, Palevsky HI, et al: Primary graft failure following lung transplantation. Chest 114:51–60, 1998.

396. Marczin N, Royston D, Yacoub M: Pro: Lung transplantation should be routinely performed with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 14:739–745, 2000.

397. Fullerton DA, McIntyre RC Jr, Mitchell MB, et al: Lung transplantation with cardiopulmonary bypass exaggerates pulmonary vasomotor dysfunction in the transplanted lung. J Thorac Cardiovasc Surg 109:212–216, discussion 216–217, 1995.

398. Gammie JS, Cheul Lee J, Pham SM, et al: Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation. J Thorac Cardiovasc Surg 115:990–997, 1998.

399. Aeba R, Griffith BP, Kormos RL, et al: Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation. Ann Thorac Surg 57:715–722, 1994.

400. Ardehali A, Laks H, Levine M, et al: A prospective trial of inhaled nitric oxide in clinical lung transplantation. Transplantation 72:112–115, 2001.

401. Meyer KC, Love RB, Zimmerman JJ: The therapeutic potential of nitric oxide in lung transplantation. Chest 113:1360–1371, 1998.

402. Lang JD Jr, Lell W: Pro: Inhaled nitric oxide should be used routinely in patients undergoing lung transplantation. J Cardiothorac Vasc Anesth 15:785–789, 2001.

403. Struber M, Harringer W, Ernst M, et al: Inhaled nitric oxide as a prophylactic treatment against reperfusion injury of the lung. Thorac Cardiovasc Surg 47:179–182, 1999.

404. Date H, Triantafillou AN, Trulock EP, et al: Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 111:913–919, 1996.

405. Thabut G, Brugiere O, Leseche G, et al: Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation. Transplantation 71:1295–1300, 2001.

406. Adatia I, Lillehei C, Arnold JH, et al: Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 57:1311–1318, 1994.

407. Mitchell JB, Shaw AD, Donald S, et al: Differential lung ventilation after single-lung transplantation for emphysema. J Cardiothorac Vasc Anesth 16:459–462, 2002.

408. Triantafillou AN, Heerdt PM, Hogue CW, et al: Epidural vs. intravenous morphine for postoperative pain management after lung transplantation [abstract]. Anesthesiology 77(3A):A858, 1992.

409. Westerlind A, Nilsson F, Ricksten SE: The use of continuous positive airway pressure by face mask and thoracic epidural analgesia after lung transplantation. Gothenburg Lung Transplant Group. J Cardiothorac Vasc Anesth 13:249–252, 1999.

410. Body S, Fanciullo G, Ferrante M, et al: Thoracic epidural analgesia after lung transplantation [abstract]. Anesthesiology 81(3A):A1285, 1994.

411. Horlocker TT, Wedel DJ: Spinal and epidural blockade and perioperative low molecular weight heparin: Smooth sailing on the Titanic. Anesth Analg 86:1153–1156, 1998.

412. Chaney MA: Intrathecal and epidural anesthesia and analgesia for cardiac surgery. Anesth Analg 84:1211–1221, 1997.

413. Rao TL, El-Etr AA: Anticoagulation following placement of epidural and subarachnoid catheters: An evaluation of neurologic sequelae. Anesthesiology 55:618–620, 1981.

414. Haddow GR: Anaesthesia for patients after lung transplantation. Can J Anaesth 44:182–197, 1997.

415. Trachiotis GD, Knight SR, Pohl MS, et al: Tidal volume and respiratory rate changes during CO2 rebreathing after lung transplantation. Ann Thorac Surg 58:1718–1720, 1994.

416. Trachiotis GD, Knight SR, Hann M, et al: Respiratory responses to CO2 rebreathing in lung transplant recipients. Ann Thorac Surg 58:1709–1717, 1994.

417. Sanders MH, Owens GR, Sciurba FC, et al: Ventilation and breathing pattern during progressive hypercapnia and hypoxia after human heart-lung transplantation. Am Rev Respir Dis 140:38–44, 1989.
2283


418. Theodore J, Jamieson SW, Burke CM, et al: Physiologic aspects of human heart-lung transplantation. Pulmonary function status of the post-transplanted lung. Chest 86:349–357, 1984.

419. Herve P, Silbert D, Cerrina J, et al: Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. The Paris-Sud Lung Transplant Group. Chest 103:59–63, 1993.

420. Robin ED, Theodore J, Burke CM, et al: Hypoxic pulmonary vasoconstriction persists in the human transplanted lung. Clin Sci (Lond) 72:283–287, 1987.

421. Suthanthiran M, Morris RE, Strom TB: Immunosuppressants: Cellular and molecular mechanisms of action. Am J Kidney Dis 28:159–172, 1996.

422. Morris RE: Mechanisms of action of new immunosuppressive drugs. Kidney Int Suppl 53:S26–S38, 1996.

423. Allison AC: Immunosuppressive drugs: The first 50 years and a glance forward. Immunopharmacology 47:63–83, 2000.

424. Helderman JH, Bennett WM, Cibrik DM, et al: Immunosuppression: Practice and trends. Am J Transplant 3(Suppl 4):41–52, 2003.

425. Kahan BD, Kramer WG: Median effect analysis of efficacy versus adverse effects of immunosuppressants. Clin Pharmacol Ther 70:74–81, 2001.

426. Euvrard S, Kanitakis J, Claudy A: Skin cancers after organ transplantation. N Engl J Med 348:1681–1691, 2003.

427. Wacher VJ, Wu CY, Benet LZ: Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 13:129–134, 1995.

428. Schuetz EG, Beck WT, Schuetz JD: Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 49:311–318, 1996.

429. Lo A, Burckart GJ: P-glycoprotein and drug therapy in organ transplantation. J Clin Pharmacol 39:995–1005, 1999.

430. Backman JT, Kivisto KT, Olkkola KT, et al: The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin. Eur J Clin Pharmacol 54:53–58, 1998.

431. Ahonen J, Olkkola KT, Takala A, et al: Interaction between fluconazole and midazolam in intensive care patients. Acta Anaesthesiol Scand 43:509–514, 1999.

432. Cirella VN, Pantuck CB, Lee YJ, et al: Effects of cyclosporine on anesthetic action. Anesth Analg 66:703–706, 1987.

433. Hoffman A, Habib G, Gilhar D, et al: Cyclosporin increases the CNS sensitivity to the hypnotic effect of phenobarbitone but not ethanol in rats. J Pharm Pharmacol 46:760–764, 1994.

434. Thompson SJ, Koszdin K, Bernards CM: Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology 92:1392–1399, 2000.

435. Hoffman A, Levy G: Kinetics of drug action in disease states. XXXVI: Effect of cyclosporine on the pharmacodynamics and pharmacokinetics of a barbiturate (heptabarbital) in rats. J Pharm Sci 79:19–22, 1990.

436. Niemann CU, Stabernack C, Serkova N, et al: Cyclosporine can increase isoflurane MAC. Anesth Analg 95:930–934, 2002.

437. Kadieva V, van Heerden PV, Roux A, et al: Neuromuscular blockade and ventilatory failure after cyclosporine. Can J Anaesth 39:402–403, 1992.

438. Ilkiw JE, Forsyth SF, Hill T, et al: Atracurium administration, as an infusion, to induce neuromuscular blockade in clinically normal and temporarily immune-suppressed cats. J Am Vet Med Assoc 197:1153–1156, 1990.

439. Sidi A, Kaplan RF, Davis RF: Prolonged neuromuscular blockade and ventilatory failure after renal transplantation and cyclosporine. Can J Anaesth 37:543–548, 1990.

440. Crosby E, Robblee JA: Cyclosporine-pancuronium interaction in a patient with a renal allograft. Can J Anaesth 35(Pt 1):300–302, 1988.

441. Gramstad L, Gjerlow JA, Hysing ES, et al: Interaction of cyclosporin and its solvent. Cremophor, with atracurium and vecuronium. Studies in the cat. Br J Anaesth 58:1149–1155, 1986.

442. Gramstad L: Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine. Br J Anaesth 59:995–1003, 1987.

443. Chapple DJ, Clark JS, Hughes R: Interaction between atracurium and drugs used in anaesthesia. Br J Anaesth 55(Suppl 1):17S–22S, 1983.

444. Kostopanagiotou G, Smyrniotis V, Arkadopoulos N, et al: Anesthetic and perioperative management of adult transplant recipients in nontransplant surgery. Anesth Analg 89:613–622, 1999.

2284

Previous Next